company background image
002864 logo

Shaanxi Panlong Pharmaceutical Group Limited By Share SZSE:002864 Stock Report

Last Price

CN¥30.21

Market Cap

CN¥3.2b

7D

-7.6%

1Y

-19.4%

Updated

23 Dec, 2024

Data

Company Financials

Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd

SZSE:002864 Stock Report

Market Cap: CN¥3.2b

002864 Stock Overview

Researches and develops, produces, and sells Chinese patent medicines in China. More details

002864 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance4/6
Financial Health5/6
Dividends3/6

Rewards

Risk Analysis

No risks detected for 002864 from our risk checks.

My Notes

Capture your thoughts, links and company narrative

Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Competitors

Price History & Performance

Summary of share price highs, lows and changes for Shaanxi Panlong Pharmaceutical Group Limited By Share
Historical stock prices
Current Share PriceCN¥30.21
52 Week HighCN¥40.50
52 Week LowCN¥22.00
Beta-0.19
1 Month Change11.56%
3 Month Change28.66%
1 Year Change-19.40%
3 Year Change-3.42%
5 Year Change14.35%
Change since IPO109.21%

Recent News & Updates

There Is A Reason Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd's (SZSE:002864) Price Is Undemanding

Sep 30
There Is A Reason Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd's (SZSE:002864) Price Is Undemanding

Recent updates

There Is A Reason Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd's (SZSE:002864) Price Is Undemanding

Sep 30
There Is A Reason Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd's (SZSE:002864) Price Is Undemanding

Shaanxi Panlong Pharmaceutical Group Limited By Share's (SZSE:002864) Shareholders Will Receive A Bigger Dividend Than Last Year

May 31
Shaanxi Panlong Pharmaceutical Group Limited By Share's (SZSE:002864) Shareholders Will Receive A Bigger Dividend Than Last Year

We Think That There Are Some Issues For Shaanxi Panlong Pharmaceutical Group Limited By Share (SZSE:002864) Beyond Its Promising Earnings

May 02
We Think That There Are Some Issues For Shaanxi Panlong Pharmaceutical Group Limited By Share (SZSE:002864) Beyond Its Promising Earnings

Earnings Not Telling The Story For Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd (SZSE:002864) After Shares Rise 32%

Mar 06
Earnings Not Telling The Story For Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd (SZSE:002864) After Shares Rise 32%

Shareholder Returns

002864CN PharmaceuticalsCN Market
7D-7.6%-1.9%-1.2%
1Y-19.4%-1.8%11.8%

Return vs Industry: 002864 underperformed the CN Pharmaceuticals industry which returned -1.8% over the past year.

Return vs Market: 002864 underperformed the CN Market which returned 11.8% over the past year.

Price Volatility

Is 002864's price volatile compared to industry and market?
002864 volatility
002864 Average Weekly Movement6.7%
Pharmaceuticals Industry Average Movement7.4%
Market Average Movement8.7%
10% most volatile stocks in CN Market12.8%
10% least volatile stocks in CN Market5.7%

Stable Share Price: 002864 has not had significant price volatility in the past 3 months compared to the CN market.

Volatility Over Time: 002864's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1997864Xiaolin Xiewww.pljt.com

Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd researches and develops, produces, and sells Chinese patent medicines in China. It offers orthopedic, cardiovascular, cerebrovascular, digestive, respiratory, pediatrics, gynecology, hepatobiliary, rheumatism and bone injury, tonic, heat-clearing and detoxifying, and liver and gallbladder drugs, as well as supplements and traditional Chinese medicine anti-inflammatory products. The company was founded in 1997 and is based in Xi'an, China.

Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Fundamentals Summary

How do Shaanxi Panlong Pharmaceutical Group Limited By Share's earnings and revenue compare to its market cap?
002864 fundamental statistics
Market capCN¥3.18b
Earnings (TTM)CN¥115.90m
Revenue (TTM)CN¥981.52m

27.4x

P/E Ratio

3.2x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
002864 income statement (TTM)
RevenueCN¥981.52m
Cost of RevenueCN¥388.49m
Gross ProfitCN¥593.03m
Other ExpensesCN¥477.13m
EarningsCN¥115.90m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)1.10
Gross Margin60.42%
Net Profit Margin11.81%
Debt/Equity Ratio9.3%

How did 002864 perform over the long term?

See historical performance and comparison

Dividends

0.7%

Current Dividend Yield

20%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 00:00
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Song YangTianfeng Securities Brokerage Co., Ltd
Tielin ChenTopsperity Securities